MRI Scan and Intra-labyrinthine Schwannoma

University Hospital, Strasbourg, France30 enrolled

Overview

Evaluate the interest of gadolinium for the positive and topographic diagnosis of intra-labyrinthine schwannoma, comparing T1 sequence acquired after gadolinium injection to a sequence of fast imaging type employing steady state acquisition (FIESTA-C)

Study Type

OBSERVATIONAL

Enrollment

Conditions

Schwannoma

Interventions

No intervention in this restrospective studyOTHER

This study is an obervational study

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18-80 years * Have intra-labyrinthine schwannoma * Have benefited from an MRI with gadolinium injection on the MRI 3T with interpretable sequences of good quality * Subject giving their consent for their participation * Subjects who benefited, between 2009 and 2016, from an MRI of the external auditory canals, with gadolinous product injection and on the 3 Tesla MRI, in which a diagnosis of intra labyrinthine schwannoma was made Exclusion Criteria: \- Refusal to participate in the study

Locations (1)

Service Imagerie 1

Strasbourg, France

RECRUITING

Outcomes

Primary Outcomes

Presence or absence of intra labyrinthine vestibular nerve tumor using T2 FIESTA alone

Time frame: 1 hour after the realization of the MRI

Central Contacts

Francis VEILLON, MD, PhD

CONTACT

33 3 88 12 78 65 Francis.veillon@chru-strasbourg.fr

Aïna VENKATASAMY, MD

CONTACT

33 3 88 12 78 65 aina.venkatasamy@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.